EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Table of Contents

The Brown University Child & Adolescent Psychopharmacology Update · 2005

DOI: 10.1002/cpu.20009 ↗
AstrattDettalji biblijografiċi

Astratt

Abstract Experts Discuss Complete Review of Published, Unpublished Data on SSRI Use in Children Evaluating the Risks for Treating Depression with SSRIs During Pregnancy FDA Recommended Frequency of Visits Oxcarbazepine in Youth with Bipolar Disorder MPH Reinforces Cigarette Smoking in Small Group of non‐ADHD Adults Boxed Warning Added to Adderall Label FDA to Reject Long‐Term Efficacy Requirement Study Finds Buprenorphine Best add‐on to Counseling MIT Launches Autism Research Initiative Severe Liver Injury with Atomoxetine FDA Warns of Liver Damage from Pemoline Cymbalta Label Extends Liver Damage Warning FDA Approves Modafinil for ADHD

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →